⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EOLS News
Evolus, Inc. Common Stock
Form 8-K
sec.gov
EOLS
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
prnewswire.com
IART
MESO
EOLS
BVS
CNXU
Evolus to Participate in The Jefferies Global Healthcare Conference
businesswire.com
EOLS
Evolus Announces Commercial Launch of Estyme ® Injectable Hyaluronic Acid Gels in Europe
businesswire.com
EOLS
Form 8-K
sec.gov
EOLS
Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook
businesswire.com
EOLS
Evolus to Report First Quarter Financial Results on May 4, 2026
businesswire.com
EOLS
Telix Appoints David Gill as Non-Executive Director
globenewswire.com
TLX
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
EOLS
Form 8-K
sec.gov
EOLS